Search results
Found 7347 matches for
Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.
©
John Cairns
Biomedical Training Courses
Our courses are aimed at people who are applying to the Home Office for Personal or Project Licences.
Find Out More
Updates about the ESM pilot